Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Seoul National University Bundang Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Phase I clinical trial to compare the pharmacokinetics and safety of CKD-348 with co-administration of CKD-828, D326 and D337 in healthy adult volunteers
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence A | Experimental | CKD-828, D326, D337, CKD-F1, CKD-F2 |
|
| Sequence B | Experimental | CKD-828, D326, D337, CKD-F1, CKD-F2 |
|
| Sequence C | Experimental | CKD-828, D326, D337, CKD-F1, CKD-F2 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 | Drug | Each arm has a different order for taking IP |
|
| Measure | Description | Time Frame |
|---|---|---|
| Cmax | Maximum plasma concentration of the drug | 0 hour ~ 144 hour |
| AUCt | Area under the concentration-time curve from time zero to time | 0 hour ~ 144 hour |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Subject who cannot participate in a clinical trial based on the PI's judgment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Seoul National University Bundang Hospital | Gyeonggi-do | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided